Iovance Biotherapeutics, Inc.
IOVA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$91,253 | -$111,658 | -$116,163 | -$78,559 |
| Dep. & Amort. | $11,708 | $11,938 | $11,065 | $11,687 |
| Deferred Tax | -$2,405 | $1,988 | -$1,838 | $1,559 |
| Stock-Based Comp. | $0 | $14,943 | $22,915 | $0 |
| Change in WC | -$8,533 | $9,190 | -$17,630 | -$37,979 |
| Other Non-Cash | $11,781 | $6,152 | -$2,043 | $29,996 |
| Operating Cash Flow | -$78,702 | -$67,447 | -$103,694 | -$73,296 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$10,844 | -$7,461 | -$6,211 | -$4,168 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$92,144 | -$68,697 | -$97,922 | -$88,155 |
| Inv. Sales/Matur. | $120,000 | $90,000 | $120,000 | $116,000 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $17,012 | $13,842 | $15,867 | $23,677 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $88,522 | $13,065 | $148,944 | $3,189 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$466 | $165 | -$5,629 | -$880 |
| Financing Cash Flow | $88,056 | $13,230 | $143,315 | $2,309 |
| Forex Effect | -$701 | $739 | $508 | -$1,182 |
| Net Chg. in Cash | $25,665 | -$39,636 | $55,996 | -$48,492 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $132,469 | $178,049 | $122,053 | $164,186 |
| End Cash | $158,134 | $138,413 | $178,049 | $115,694 |
| Free Cash Flow | -$89,546 | -$74,908 | -$109,905 | -$77,464 |